Covishield can be available in first half of 2021
Serum Institute has currently applied with the DCGI for emergency authorization of Covishield in the country
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Oxford University
Oxford COVID-19 vaccine trials produce robust immune response in elderly: FT
AstraZeneca, which is developing the vaccine with Oxford University researchers, is seen as a frontrunner in the race to produce a…
Brazil volunteer in AstraZeneca COVID-19 vaccine trial dies, trial to go on
Sources say that the trial would have been suspended if the volunteer who died had received the COVID-19 vaccine, suggesting the…
Phase III trials of Covishield vaccine in Pune next week
Around 150 to 200 volunteers will be administered the vaccine candidate dose
UK researchers to test inhaled versions of Oxford and Imperial COVID-19 vaccine candidates
Delivering the vaccine to the respiratory tract may be a good approach to inducing immune responses in the best place to enable a…
Clinical trials of AstraZeneca-Oxford COVID-19 vaccine candidate resumes in UK
This is following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so
Patient activist groups express relief over pause of Covishield trials in India
They call for more timely responses and accountability on part of both regulators and companies to ensure patient safety
SII pauses trials of COVID-19 vaccine candidate Covishield in India
The company took this step after the DCGI issued a show cause notice to the company for not informing it about AstraZeneca…
DCGI issues notice to Serum Institute over AstraZeneca-Oxford COVID-19 vaccine trial suspension
If DCGI has any safety concerns, we will follow their instructions and abide by the standard protocol, said SII in response to…
Phase III trials of AstraZeneca COVID-19 vaccine candidate begins in US
AZD1222 is already undergoing late-stage clinical trials in Britain, Brazil and South Africa, with additional trials planned in…